Evidence map›Paper›PMID 32377912›Full record

ArticleInternational journal of colorectal disease2020

A risk model for prediction of 30-day readmission rates after surgical treatment for colon cancer.

Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Chintan Bhatt, Sankalp Das, Emir Veledar, Peter McGranaghan, Ana Viamonte-Ros, Yazmin Odia, Michael Chuong and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Development of a Clinical Decision Support System to Predict Unplanned Cancer Readmissions.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Muni RubensMiami Cancer Institute, Baptist Health South Florida, 8900 N. Kendall Dr. 1st Floor, Research Bldg, Radiation Oncology Executive Office, Miami, FL, 33176, USA.ORCID http://orcid.org/0000-0003-1812-9753
Venkataraghavan RamamoorthyUniversity of Central Missouri, Warrensburg, MO, USA.
Anshul SaxenaBaptist Health South Florida, Miami, FL, USA.
Chintan BhattBaptist Health South Florida, Miami, FL, USA.
Sankalp DasBaptist Health South Florida, Miami, FL, USA.
Emir VeledarBaptist Health South Florida, Miami, FL, USA.
Peter McGranaghanMiami Cancer Institute, Baptist Health South Florida, 8900 N. Kendall Dr. 1st Floor, Research Bldg, Radiation Oncology Executive Office, Miami, FL, 33176, USA.
Ana Viamonte-RosBaptist Health South Florida, Miami, FL, USA.
Yazmin OdiaMiami Cancer Institute, Baptist Health South Florida, 8900 N. Kendall Dr. 1st Floor, Research Bldg, Radiation Oncology Executive Office, Miami, FL, 33176, USA.
Michael ChuongMiami Cancer Institute, Baptist Health South Florida, 8900 N. Kendall Dr. 1st Floor, Research Bldg, Radiation Oncology Executive Office, Miami, FL, 33176, USA.
Rupesh KotechaMiami Cancer Institute, Baptist Health South Florida, 8900 N. Kendall Dr. 1st Floor, Research Bldg, Radiation Oncology Executive Office, Miami, FL, 33176, USA.
Minesh P MehtaMiami Cancer Institute, Baptist Health South Florida, 8900 N. Kendall Dr. 1st Floor, Research Bldg, Radiation Oncology Executive Office, Miami, FL, 33176, USA. mineshm@baptisthealth.net.
Baptist Hospital of Miami · USBaptist Health South Florida · USUniversity of Central Missouri · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this study was to develop a risk model for the prediction of 30-day unplanned readmission rate after surgery for colon cancer.

methodThis study was a cross-sectional analysis of data from Nationwide Readmissions Database, collected during 2010-2014. Patients ≥ 18 years of age who underwent surgery for colon cancer were included in the study. The primary outcome of the study was 30-day unplanned readmission rate.

resultsThere were 141,231 index hospitalizations for surgical treatment of colon cancers and 16,551 had unplanned readmissions. Age, sex, primary payer, Elixhauser comorbidity index, node positive or metastatic disease, length of stay, hospital bedsize, teaching status, hospital ownership, presence of stoma, surgery types, surgery procedures, infectious complications, surgical complications, mechanical wounds, pulmonary complications, and gastrointestinal complications were selected for the risk analysis during backward regression model. Based on the estimated coefficients of selected variables, risk scores were developed and stratified as low risk (≤ 1.08), moderate risk (> 1.08 to ≤ 1.5), and high risk (> 1.5) for unplanned readmission. Validation analysis (n = 42,269) showed that 7.1% of low-risk individuals, 11.1% of moderate-risk individuals, and 17.1% of high-risk individuals experienced unplanned readmissions (P < 0.001). Pairwise comparisons also showed statistically significant differences between low-risk and moderate-risk participants (P < 0.001), between moderate-risk and high-risk participants (P < 0.001), and between low-risk and high-risk participants (P < 0.001). The area under the ROC curve was 0.622.

conclusionsOur risk model could be helpful for risk-stratifying patients for readmission after surgical treatment for colon cancer. This model needs further validation by incorporating all possible clinical variables.

Indexed as

Colonic NeoplasmsPatient ReadmissionCross-Sectional StudiesDatabases, FactualHumansPostoperative ComplicationsRetrospective StudiesRisk FactorsTime FactorsColon cancerReadmissionRisk modelRisk scoreRisk stratificationSurgery

Identifiers

PMID32377912
OpenAlexW3023321148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.